Veru (NASDAQ: VERU) director receives 104,000 stock options grant

Rhea-AI Filing Summary

VERU INC. director Lucy Lu reported receiving a grant of 104,000 common stock options as compensation. The options have an exercise price of $2.25 per share and expire on May 4, 2036. One-third of the options vest on each of May 4, 2027, May 4, 2028, and May 4, 2029, and Lu holds 104,000 options following this grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lu Lucy

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Option	104,000	$0.00	--

Holdings After Transaction: Common Stock Option — 104,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 104,000 options Exercise price: $2.25 per share Total options after grant: 104,000 options +2 more

5 metrics

Options granted 104,000 options Common Stock Option grant reported on Form 4

Exercise price $2.25 per share Exercise price for the 104,000 stock options

Total options after grant 104,000 options Total options held by Lucy Lu following the transaction

Option expiration date May 4, 2036 Final expiry date of the granted options

Vesting schedule start May 4, 2027 First vesting date for one-third of the options

Key Terms

Common Stock Option, exercise price, expiration date, vesting, +1 more

5 terms

Common Stock Option financial

"The security reported is a Common Stock Option with underlying Common Stock."

exercise price financial

"The options carry an exercise price of $2.25 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"The option award has an expiration date of May 4, 2036."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"Options for one-third of the shares vest on each of May 4, 2027, May 4, 2028 and May 4, 2029."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Grant, award, or other acquisition financial

"The transaction code description is Grant, award, or other acquisition."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Lucy

(Last) (First) (Middle)

2916 N. MIAMI AVENUE

SUITE 1000

(Street)

MIAMI FLORIDA 33127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERU INC. [ VERU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Option	$2.25	05/04/2026		A		104,000		05/04/2027(1)	05/04/2036	Common Stock	104,000	$0	104,000	D

Explanation of Responses:

1. Options for one-third of the shares vest on each of May 4, 2027, May 4, 2028 and May 4, 2029.

	/s/ Phil R. Greenberg, via Power of Attorney	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did VERU director Lucy Lu report on this Form 4?

Lucy Lu reported receiving a grant of 104,000 common stock options from VERU INC. This is a compensation-related award, not an open-market stock purchase or sale, and is classified as an acquisition under transaction code A on the Form 4.

How many VERU INC. stock options were granted to Lucy Lu and at what price?

Lucy Lu was granted 104,000 common stock options of VERU INC. Each option carries an exercise price of $2.25 per share, meaning she can buy shares at $2.25 once the options vest and subject to other plan conditions.

What is the vesting schedule for Lucy Lu’s VERU stock option grant?

The 104,000 options vest in three equal installments. One-third of the options vest on May 4, 2027, another third on May 4, 2028, and the final third on May 4, 2029, aligning vesting with multi-year service at the company.

When do Lucy Lu’s VERU stock options expire under this grant?

Lucy Lu’s 104,000 VERU INC. stock options expire on May 4, 2036. After that date, any unexercised options become worthless, so the exercise opportunity is limited to the period between each vesting date and this expiration date.

Is Lucy Lu’s Form 4 transaction in VERU shares a market buy or sell?

The filing shows a grant of stock options, not a market buy or sell of shares. Transaction code A reflects a grant or award acquisition at a grant price of $0.00, with a separate $2.25 per share exercise price for future potential share purchases.